Table 1.
Demographic and clinical features of the enrolled SLE patients.
| Characteristics | SLE | Healthy control |
|---|---|---|
| Age, mean (SD), years | 37.41 (14.70) | 33.85 (9.10) |
| Sex, female, n (%) | 33 (84.62%) | 8 (80%) |
| Disease duration, mean (SD), months | 75.71 (78.70) | |
| Clinical manifestation, n (%) | ||
| Skin rash | 19 (48.72%) | |
| Arthritis | 15 (38.40%) | |
| Serositis | 7 (17.95%) | |
| Nephritis | 22 (56.41%) | |
| Lung involvement | 15 (38.46%) | |
| Hematologic disorder | 24 (61.54%) | |
| Immunological parameters, n (%) | ||
| ANA positive | 39 (100%) | |
| Anti-Smith positive | 19 (48.72%) | |
| Anti-dsDNA positive | 19 (48.72%) | |
| Low complement C3 or C4 | 14 (35.90%) | |
| SLEDAI score, mean (SD) | 10.76 (4.77) |